Tags |
|
|
Links |
|
|
Article Dump - Colitis Explained
There are a diverse range of diseases that affect various areas of the digestive tract. Many of these conditions, grouped in the category of irritable bowel
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
disease (IBD), are indistinguishable from other similar diseases like Crohn’s Disease and Irritable Bowl Syndrome, thus, diagnosis is often a complicated a
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
nd you must adopt a trial-and-error approach.
Colitis is a disease that results in the inflammation of the lining of the large intestine, or colon. Researc
Colitis is a disease that results in the inflammation of the lining of the large intestine, or colon. Researc
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
hers have estimated that as many as two million people in the United States may suffer from colitis, many of them undiagnosed. The majority of cases manifes
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
t rather early in life – before the age of thirty – although it is not uncommon for people of any age to develop the disease. Research on colitis has reveal
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ed that prevalence is not affected by gender.
The disease can either be acute or chronic and results in ulcers being formed in the upper membrane layers of
The disease can either be acute or chronic and results in ulcers being formed in the upper membrane layers of
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
the colon. Colitis, like other forms of IBD, wreaks havoc on the digestive tract. When the colon becomes inflamed many of the cells die and this tissue dea
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
th spurs the production of ulcers. Ulcers may bleed and generate pus leading to severe abdominal cramping, diarrhea, painful abdominal sensations, reduced a
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ppetite, infections, fatigue, weight loss, and fever.
As is the case with other forms of IBD, the causes of colitis are shrouded in mystery. There are a nu
As is the case with other forms of IBD, the causes of colitis are shrouded in mystery. There are a nu
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
mber of competing theories as to the cause, but none have been proven as of yet. Since colitis is believed to be spurred through inflammation, many scientis
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ts point to infection as the leading cause. There is also some evidence that genetics and family connection plays a part. There is also research into coliti
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
s as potentially being related to an autoimmune response by the body. It appears that colitis may be triggered by the body attacking itself. Various bacteri
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
al, viral, and protozoan infections have also been bandied about as possible triggers of colitis. According to research, smokers are twice as likely to deve
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
lop colitis then are non-smokers.
If left untreated, colitis can lead to severe medical problems. As stated previously, the diagnosis of colitis can be tri
If left untreated, colitis can lead to severe medical problems. As stated previously, the diagnosis of colitis can be tri
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
cky since many forms of IBD may appear similar upon cursory examination. It can take some time to achieve an accurate diagnosis. Fortunately, even though th
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
e causes of colitis are not fully understood, there are treatments available for the disease. Treatment often varies due to the severity of the flare up. Co
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
litis, like other forms of IBD, is usually treated via prescription drugs. In advanced cases, surgery to remove the colon may be required, and as of this ti
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
me is the only cure.
It is important to remember that colitis is a disease that will affect each person differently. There is no standard procedure that ca
It is important to remember that colitis is a disease that will affect each person differently. There is no standard procedure that ca
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
n be followed for every case. Furthermore, the psychological ramifications from the disease cannot be ignored. Many people experience depression due to the
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
impact of physical symptoms on quality of life. If you are suffering from colitis it is important to schedule regular medical visits to monitor the disease.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.articledump.org.ua/article/242752/articledump-Colitis-Explained.html">Colitis Explained</a>
BB link (for phorums):
[url=http://www.articledump.org.ua/article/242752/articledump-Colitis-Explained.html]Colitis Explained[/url]
Related Articles:
McDonalds Supply Chain of Potatoes
Business Development Tips For An Outsourcing Business
Bookmark it:
|